Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy

Elisabeth Isenring; Giordana Cross; Lynne Daniels; Elizabeth Kellett; Bogda Koczwara

doi:10.1007/s00520-006-0070-5

Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy

Elisabeth Isenring^*
, Giordana Cross
, Lynne Daniels
, Elizabeth Kellett
, Bogda Koczwara

^*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

155 Citations (Scopus)

Abstract

Goals of work: To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy. Patients and methods: An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients. Main results: According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001). Conclusion: The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.

Original language	English
Pages (from-to)	1152-1156
Number of pages	5
Journal	Supportive Care in Cancer
Volume	14
Issue number	11
DOIs	https://doi.org/10.1007/s00520-006-0070-5
Publication status	Published - Nov 2006
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 2 Zero Hunger

Access to Document

10.1007/s00520-006-0070-5

https://rdcu.be/coj62Licence: Other

Oncology Nutrition Research
Isenring, E. (Project Lead), Marshall, S. (Senior Research Fellow), Van der Meij, B. (Senior Research Fellow), Rigby, R. (Associate Investigator), Teleni, L. (HDR Student), Crichton, M. (HDR Student) & Tang, X. (Admin)
1/01/14 → …
Project: Research
Ageing Nutrition: Research Across the Care Continuum
Marshall, S. (Project Lead), Isenring, E. (Professor), Hugo, C. (HDR Student), Agarwal, E. (Assistant Professor), Teleni, L. (HDR Student), Reidlinger, D. (Associate Professor), Campbell, K. (Associate Professor), Van der Meij, B. (Senior Research Fellow) & Tang, X. (Admin)
1/01/14 → …
Project: Research

Cite this

@article{35c02d1df2294a9581997dab35244066,

title = "Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy",

abstract = "Goals of work: To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy. Patients and methods: An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients. Main results: According to PG-SGA global rating, the prevalence of malnutrition was 26\%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100\% sensitivity, 92\% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001). Conclusion: The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.",

author = "Elisabeth Isenring and Giordana Cross and Lynne Daniels and Elizabeth Kellett and Bogda Koczwara",

year = "2006",

month = nov,

doi = "10.1007/s00520-006-0070-5",

language = "English",

volume = "14",

pages = "1152--1156",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer",

number = "11",

}

TY - JOUR

T1 - Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy

AU - Isenring, Elisabeth

AU - Cross, Giordana

AU - Daniels, Lynne

AU - Kellett, Elizabeth

AU - Koczwara, Bogda

PY - 2006/11

Y1 - 2006/11

N2 - Goals of work: To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy. Patients and methods: An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients. Main results: According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001). Conclusion: The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.

AB - Goals of work: To determine the relative validity of the Malnutrition Screening Tool (MST) compared with a full nutrition assessment by the scored Patient Generated-Subjective Global Assessment (PG-SGA) and to assess MST inter-rater reliability in patients receiving chemotherapy. Patients and methods: An observational, cross-sectional study was conducted at an Australian public hospital in 50 oncology outpatients receiving chemotherapy. Inter-rater reliability was assessed in a subsample of 20 patients. Main results: According to PG-SGA global rating, the prevalence of malnutrition was 26%. The MST was a strong predictor of nutritional risk relative to the PG-SGA (100% sensitivity, 92% specificity, 0.8 positive predictive value, 1.0 negative predictive value). MST inter-rater reliability was acceptable with agreement by administration staff/nursing staff/patient and the dietitian in 18/20 cases (kappa=0.83; p0.001). Conclusion: The MST has acceptable relative validity, inter-rater reliability, sensitivity, and specificity to identify chemotherapy outpatients at risk of malnutrition and, hence, is an acceptable nutrition screening tool in this patient population.

U2 - 10.1007/s00520-006-0070-5

DO - 10.1007/s00520-006-0070-5

M3 - Article

SN - 0941-4355

VL - 14

SP - 1152

EP - 1156

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 11

ER -

Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy

Abstract

UN SDGs

Access to Document

Fingerprint

Related Projects

Oncology Nutrition Research

Ageing Nutrition: Research Across the Care Continuum

Cite this